A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Clinical trial NCT07708753 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07708753
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer Platinum-resistant Primary Peritoneal Cancer Platinum-resistant Fallopian Tube Cancer

Start date: 2026-07-01
Primary completion: 2029-10-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.